Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sensei Biotherapeutics Inc.

www.senseibio.com

Latest From Sensei Biotherapeutics Inc.

Venture Funding Deals, January 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging life science companies that have received venture funding, including companies within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced November through December 2015.

BioPharmaceutical Medical Device

Scrip Asia 100: Sales Blown Off Course By Currency Headwinds

Fiscal 2013 was a difficult year for Asian drug producers. 2013 drug revenues were $128 billion, 5.1% down on 2012 levels ($136 billion) across the 85 publicly-traded pharmaceutical companies that constitute the Scrip Asia 100.

BioPharmaceutical China

Powerful Parliamentary Committee Slams India’s Drug Regulator; Calls For Swift Overhaul

The committee unravels a system full of questionable practices and recommends complete overhaul of India’s drug regulator.

BioPharmaceutical India

Panacea Pharmaceuticals Inc.

Panacea Pharmaceuticals is developing products to detect and treat CNS diseases and cancer.
BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Vaccines
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Panacea Pharmaceuticals Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Sensei Biotherapeutics Inc.
  • Senior Management
  • John K Celebi, Pres. & CEO
    Steven Fuller, PhD, COO
    Pauline Callinan, PhD, VP, Bus. Dev.
    Ildiko Csiki, MD, PhD, CMO
    Hossein A Ghanbari, PhD, CSO
  • Contact Info
  • Sensei Biotherapeutics Inc.
    Phone: (240) 243-8000
    620 Professional Dr.
    Gaithersburg, MD 20879
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register